Abstract
Preimplantation genetic screening (PGS) is used in an effort to decrease spontaneous miscarriage, prevent the birth of aneuploid offspring and to increase the delivery rate by removing genetically abnormal embryos from the pool of embryos to be transferred. The most currently available information regarding aneuploidy rates among human preimplantation embryos comes from PGS of embryos from patients with impaired fertility. PGS for aneuploidy is not a common recommendation for the donor egg patient group.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
